Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Special Issue

KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025

Won Sohn, Young-Sun Lee, Soon Sun Kim, Jung Hee Kim, Young-Joo Jin, Gi-Ae Kim, Pil Soo Sung, Jeong-Ju Yoo, Young Chang, Eun Joo Lee, Hye Won Lee, Miyoung Choi, Su Jong Yu, Young Kul Jung, Byoung Kuk Jang, on behalf of The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2025;31(Suppl):S1-S31. Published online February 19, 2025

DOI: https://doi.org/10.3350/cmh.2025.0045

View: 1231 Download: 154 Web of Science: 2 Crossref: 2

Reply to Correspondence

Reply to correspondence on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”

Jeayeon Park, Su Jong Yu

Clin Mol Hepatol. 2025;31(2):e221-e223. Published online March 4, 2025

DOI: https://doi.org/10.3350/cmh.2025.0226

View: 493 Download: 7

Editorial

Revealing the importance of a multidisciplinary approach to reducing the global burden of SLD through the COVID-19 pandemic: Editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023”

Jeayeon Park, Su Jong Yu

Clin Mol Hepatol. 2025;31(2):625-627. Published online January 16, 2025

DOI: https://doi.org/10.3350/cmh.2025.0019

View: 759 Download: 19 Crossref: 2

Original Article

Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study

Moon Haeng Hur, Dong Hyeon Lee, Jeong-Hoon Lee, Mi-Sook Kim, Jeayeon Park, Hyunjae Shin, Sung Won Chung, Hee Jin Cho, Min Kyung Park, Heejoon Jang, Yun Bin Lee, Su Jong Yu, Sang Hyub Lee, Yong Jin Jung, Yoon Jun Kim, Jung-Hwan Yoon

Clin Mol Hepatol. 2024;30(3):500-514. Published online May 10, 2024

DOI: https://doi.org/10.3350/cmh.2024.0055

View: 3610 Download: 192 Web of Science: 3 Crossref: 4

Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma

Jeayeon Park, Sung Won Chung, Yun Bin Lee, Hyunjae Shin, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jeonghwan Youk, Ji Yun Lee, Jeong-Ok Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Tae Min Kim, Jeong-Hoon Lee

Clin Mol Hepatol. 2023;29(3):794-809. Published online May 17, 2023

DOI: https://doi.org/10.3350/cmh.2023.0057

View: 4812 Download: 177 Web of Science: 2 Crossref: 1

Inhibition of PI3K/Akt signaling suppresses epithelial-to-mesenchymal transition in hepatocellular carcinoma through the Snail/GSK-3/beta-catenin pathway

Seulki Lee, Eun Ji Choi, Eun Ju Cho, Yun Bin Lee, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim

Clin Mol Hepatol. 2020;26(4):529-539. Published online August 24, 2020

DOI: https://doi.org/10.3350/cmh.2019.0056n

View: 10264 Download: 272 Web of Science: 40 Crossref: 39

Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment

Cheol-Hyung Lee, Yun Bin Lee, Minseok Albert Kim, Heejoon Jang, Hyunwoo Oh, Sun Woong Kim, Eun Ju Cho, Kyung-Hun Lee, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Tae-You Kim, Yoon Jun Kim

Clin Mol Hepatol. 2020;26(3):328-339. Published online May 28, 2020

DOI: https://doi.org/10.3350/cmh.2019.0049n

View: 9972 Download: 351 Web of Science: 35 Crossref: 34

Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients

Goh Eun Chung, Eun Ju Cho, Jeong-Hoon Lee, Jeong-ju Yoo, Minjong Lee, Yuri Cho, Dong Hyeon Lee, Hwi Young Kim, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Fabien Zoulim

Clin Mol Hepatol. 2017;23(1):66-73. Published online February 14, 2017

DOI: https://doi.org/10.3350/cmh.2016.0060

View: 11031 Download: 170 Web of Science: 12 Crossref: 11

Case Report

Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases

Hyeki Cho, Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Kook-Hwan Oh, Kyoungbun Lee, Syifa Mustika, Jung-Hwan Yoon, Yoon Jun Kim

Clin Mol Hepatol. 2016;22(2):286-291. Published online June 25, 2016

DOI: https://doi.org/10.3350/cmh.2015.0066

View: 11567 Download: 176 Web of Science: 11 Crossref: 13

Review

A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016

Su Jong Yu

Clin Mol Hepatol. 2016;22(1):7-17. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.7

View: 21373 Download: 557 Web of Science: 230 Crossref: 215

Original Article

Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea

Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim

Clin Mol Hepatol. 2015;21(4):358-364. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.358

View: 9221 Download: 111 Web of Science: 12 Crossref: 11

Editorial

Regression of liver cirrhosis: Orthodoxy or paradigm shift?

Su Jong Yu

Clin Mol Hepatol. 2015;21(1):22-23. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.22

View: 7155 Download: 91 Web of Science: 2 Crossref: 1

Original Article

Validation of P2/MS for reflecting hepatic fibrosis in patients with hepatocellular carcinoma

Su Jong Yu, Jeong-Hoon Lee, Goh Eun Chung, Chang-Hoon Lee, Eun Ju Cho, Eun Sun Jang, Min-Sun Kwak, Yoon Jun Kim, Jung-Hwan Yoon, Ja-June Jang, Hyo-Suk Lee

Clin Mol Hepatol. 2010;16(4):389-396. Published online December 31, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.4.389

View: 8454 Download: 56 Crossref: 1

1 |

Viewed By 10917	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7640	MAFLD: How is it different from NAFLD?
Viewed By 5527	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4983	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Viewed By 4892	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma

Cited By 342	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 305	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 210	MAFLD: How is it different from NAFLD?
Cited By 104	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Cited By 104	Non-alcoholic fatty liver disease: Definition and subtypes

Search